| Leah | It's OK http://accesstocompletion.com/desvenlafaxine-blog.pdf desvenlafaxine fumarate Bydureon, acquired through Bristol's recent purchase ofAmylin Pharmaceuticals, posted quarterly sales of $66 million,almost $50 million below Fernandez's forecast. He said theinjectable drug is facing tough competition from Novo Nordisk's Victoza, and warned new rivals will emerge in thenext few years. |
|